2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |
Christman BW et al. | An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. | 1992 | N. Engl. J. Med. | pmid:1603138 |
FitzGerald GA et al. | Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. | 1984 | N. Engl. J. Med. | pmid:6231483 |
Goldberg MR et al. | Prostacyclin biosynthesis and platelet function in autonomic dysfunction. | 1985 | Neurology | pmid:3838109 |
Yuhki K et al. | [Prostaglandin I2 and its metabolites]. | 2010 | Nippon Rinsho | pmid:20960743 |
Ylikorkala O et al. | Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. | 1988 | Obstet Gynecol | pmid:3275910 |
Rauramo I et al. | Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise. | 1995 | Obstet Gynecol | pmid:7770249 |
Saareks V et al. | Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. | 2002 | Pharmacol. Toxicol. | pmid:12403056 |
McAdam BF et al. | Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9874808 |
Praticò D et al. | Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11248083 |